Dermatophagoides Pteronyssinus

• In vivo biological standardization of Dermatophagoides allergen extracts. Not authorised
  2024-514108-15-00 Phase II 1 country Advanced Outcomes Research S.L.; Asac Pharmaceutical Inmunology S.A.
• A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting
  2025-524580-21-00 Phase II/III 1 country Inmunotek S.L.
• Dose determination study of a mix of Dermatophagoides allergenic extracts (pteronyssinus and farinae) for immunotherapy treatment, administe… Recruiting
  2025-521522-15-00 Phase II 1 country Advanced Outcomes Research S.L.; Asac Pharmaceutical Inmunology S.A.
• In vivo biological standardization of Dermatophagoides allergen extracts. Ended
  2024-514108-15-01 Phase II 1 country Asac Pharmaceutical Inmunology S.A.
• Study to evaluate the safety and efficacy of a treatment consisting of immunotherapy by subcutaneous injection of a combination of Der p 1/D… Ended
  2024-518519-20-01 Phase II 1 country Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.
• A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended
  2024-515717-17-00 Phase III 1 country Inmunotek S.L.
• BIOLOGICAL STANDARDISATION OF ALLERGENIC EXTRACTS OF MITES TO DETERMINE BIOLOGICAL ACTIVITY (IN HEP UNITS) IN SENSITIVISED PATIENTS. Ended
  2024-513834-40-01 Phase II 1 country Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.
• A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutane… Ended
  2023-504942-75-01 Phase III 6 countries HAL Allergy B.V.

Showing 1–8 of 8 trials